Breast Neoplasms
Showing NaN - NaN of 34
Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,
Recruiting
- Breast Neoplasms
- +2 more
- Trastuzumab Deruxtecan
- +5 more
-
Springdale, Arkansas
- +203 more
Jan 13, 2023
Breast Tumors Trial in Israel, Korea, Republic of, United States (Atezolizumab (MPDL3280A), an engineered anti-programmed
Active, not recruiting
- Breast Neoplasms
- Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody
- +7 more
-
Birmingham, Alabama
- +26 more
Dec 21, 2022
Breast Tumors Trial in Worldwide (PD-0332991, Letrozole, Placebo)
Active, not recruiting
- Breast Neoplasms
- PD-0332991
- +2 more
-
Bellflower, California
- +304 more
Dec 6, 2022
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)
Active, not recruiting
- Breast Neoplasms
- Abemaciclib
- +2 more
-
Fayetteville, Arkansas
- +141 more
Nov 15, 2022
Breast Tumors, Tumor Metastasis Trial in Worldwide (Imlunestrant, Exemestane, Fulvestrant)
Recruiting
- Breast Neoplasms
- Neoplasm Metastasis
- Imlunestrant
- +3 more
-
Chandler, Arizona
- +238 more
Aug 17, 2022
Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib, Physician's-Choice)
Completed
- Breast Neoplasms
- +2 more
-
Flagstaff, Arizona
- +361 more
Dec 20, 2021
Breast Cancer, Breast Tumors Trial in United States (Bevacizumab, Anastrozole, Fulvestrant)
Completed
- Breast Cancer
- Breast Neoplasms
- Bevacizumab
- +2 more
-
Fort Myers, Florida
- +10 more
Nov 16, 2021
Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib)
Terminated
- Breast Neoplasms
- +2 more
-
Greenbrae, California
- +70 more
Oct 10, 2019
NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)
Terminated
- Carcinoma, Non-Small-Cell Lung
- +7 more
-
Birmingham, Alabama
- +10 more
Jul 17, 2019
Breast Tumors Trial in Worldwide (Carboplatin, Docetaxel, Pertuzumab)
Breast Cancer, Breast Tumors Trial in Spain, United States (XL147 (SAR245408), trastuzumab, paclitaxel)
Completed
- Breast Cancer
- Breast Neoplasms
- XL147 (SAR245408)
- +2 more
-
Los Angeles, California
- +8 more
May 9, 2016
Breast Tumors, Osteoporosis Trial in Puerto Rico, United States (Zoledronic Acid, Letrozole)
Completed
- Breast Neoplasms
- Osteoporosis
- Zoledronic Acid
- Letrozole
-
Springdale, Arkansas
- +43 more
Feb 21, 2014
Breast Tumors, Breast Cancer Trial in United States (Vinflunine, Trastuzumab)
Completed
- Breast Neoplasms
- Breast Cancer
-
Anniston, Alabama
- +9 more
Jul 9, 2013
Breast Tumors Trial in Worldwide (Sunitinib + Capecitabine, Capecitabine)
Completed
- Breast Neoplasms
- Sunitinib + Capecitabine
- Capecitabine
-
Downey, California
- +168 more
Jun 15, 2012
Breast Tumors, Lung Tumors, Ovarian Tumors Trial in Nashville, San Antonio (Laboratory Assay, Mick Assay)
Completed
- Breast Neoplasms
- +3 more
- Laboratory Assay
- Mick Assay
-
Nashville, Tennessee
- +2 more
Jan 25, 2012